PYOTT DAVID E I received a stock award from ALNYLAM PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/22/2026ACC: 0001178670-26-000039
Director
Since Jul 2019
+2.11K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
2.11K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+671.00
Price / share
—
Trade value
—
% of position
73.7%
5/20/2026
911.00→1.58K
Total
Net shares
+671.00
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/20/2026 | A · Award | +671.00 | — | — | 73.7% | 911.00 | 1.58K |
| Total | +671.00 | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
1.44K shares
Shares
+1.44K
Strike price
298.48
Held after
1.44K
Exercisable
—
5/20/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock1.44K shares | 5/20/2026 | A · Award | +1.44K | 298.48 | — | 1.44K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned27.90K
Total
27.90K indirect27.90K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 27.90K | Indirect |
| Total | 27.90K | 27.90K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported